Skip to content
Screener

Ocular Therapeutix OCUL Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

EyePoint, Inc. logo
EyePoint, Inc.EYPT
$19.84M-5.9%
KLR
Kalaris TherapeuticsKLRS
$1.43M
HRO
HarrowHROW
$7.39M+9,139,678,516%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
11.4%+0.4pp
Schering-Plough logo
Schering-PloughSGP
6.4%-0.1pp
PTH
Pelthos TherapeuticsPTHS
8.4%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.03B-7.1%
Enterprise value$1.44B-22.9%
P/S39×+0.4×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-055256
Line itemMarch 31, 2026December 31, 2025
Total current assets705,995782,129
Property and equipment, net18,42519,676
Restricted cash1,6141,614
Operating lease assets6,4954,638
Total assets$732,529$808,057
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$8,026$4,154

Item 1. Financial Statements (unaudited)

FAQ

What is Ocular Therapeutix's operating lease ROU assets?
Ocular Therapeutix (OCUL) reported operating lease ROU assets of $6.5M in Q1 2026.
How has Ocular Therapeutix's operating lease ROU assets changed year-over-year?
Ocular Therapeutix's operating lease ROU assets increased by 11.4% year-over-year, from $5.83M to $6.5M.
What is the long-term trend for Ocular Therapeutix's operating lease ROU assets?
Over 5 years (2020 to 2025), Ocular Therapeutix's operating lease ROU assets has grown at a -4.5% compound annual growth rate (CAGR), from $5.84M to $4.64M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Ocular Therapeutix's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude